AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35820778 — intervention group
Group type: EXPERIMENTAL
Intervention: Association of days between visits and spontaneous clearance
Number of subjects: 221
Study 33025652 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 0
Study 33025652 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (CCBs)
Number of subjects: 0
Study 33025652 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium-sparing diuretics and aldosterone antagonists
Number of subjects: 0
Study 33025652 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasodilator antihypertensives
Number of subjects: 0
Study 33025652 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blockers (ARBs)
Number of subjects: 0
Study 33025652 — intervention group
Group type: EXPERIMENTAL
Intervention: Other classes of hypertensives
Number of subjects: 0
Study 32985036 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM)
Number of subjects: 40
Study 32985036 — intervention group
Group type: COMPARATOR
Intervention: Standard manual therapy (MT)
Number of subjects: 40
Study 610148118 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern diet (9217.6 kJ, macronutrient composition 331.7:66.1:76.9 g)
Number of subjects: 19
Study 610148118 — intervention group
Group type: COMPARATOR
Intervention: Traditional diet (8807.3 kJ, macronutrient composition 364.3:30.1:66.4 g)
Number of subjects: 19
Study 610148118 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern diet
Number of subjects: 19
Study 36170319 — intervention group
Group type: EXPERIMENTAL
Intervention: Locator-retained maxillary overdentures (LOD)
Number of subjects: 60
Study 36170319 — intervention group
Group type: COMPARATOR
Intervention: Maxillary conventional dentures (maxillary CD)
Number of subjects: 60
Study 36170319 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary overdentures (maxillary OD)
Number of subjects: 60
Study 36170319 — intervention group
Group type: COMPARATOR
Intervention: Bar overdentures (BOD)
Number of subjects: 60
Study 36170319 — intervention group
Group type: COMPARATOR
Intervention: Resilient telescopic overdentures (TOD)
Number of subjects: 60
Study 33620470 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibetree Pain‐Relieving Plaster (PRP)
Number of subjects: 50
Study 32181499 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held localized vibrational massage device
Number of subjects: 40
Study 32181499 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous application of the vibrational massage device
Number of subjects: 40
Study 32181499 — intervention group
Group type: COMPARATOR
Intervention: Cessation of treatment (regression subgroup)
Number of subjects: 40
Study 36454889 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed, Agility and Quickness (SAQ) training
Number of subjects: 21
Study 36454889 — intervention group
Group type: COMPARATOR
Intervention: Soccer-specific training based on small-sided games (SSG)
Number of subjects: 21
Study 34225066 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus + AIs (exemestane or letrozole or anastrozole)
Number of subjects: 110
Study 34225066 — intervention group
Group type: COMPARATOR
Intervention: AIs alone (AI monotherapy)
Number of subjects: 110
Study 35320619 — intervention group
Group type: EXPERIMENTAL
Intervention: Large DBBM particles (1-2 mm)
Number of subjects: 32
Study 35320619 — intervention group
Group type: COMPARATOR
Intervention: Small DBBM particles (0.25-1 mm)
Number of subjects: 32
Study 35320619 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study 33610954 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 92
Study 33610954 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Splint (MAS) therapy
Number of subjects: 92
Study 32913173 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching
Number of subjects: 60
Study 32913173 — intervention group
Group type: EXPERIMENTAL
Intervention: Microabrasion
Number of subjects: 60
Study 32913173 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin Infiltration
Number of subjects: 60
Study 35718069 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable distal caps
Number of subjects: 400
Study 35718069 — intervention group
Group type: COMPARATOR
Intervention: Fixed distal caps
Number of subjects: 400
Study 35718069 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups after HLD
Number of subjects: 400
Study 33290937 — intervention group
Group type: EXPERIMENTAL
Intervention: Cat adoption (treatment group)
Number of subjects: 11
Study 33290937 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention for 18 weeks)
Number of subjects: 11
Study 33543735 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality vestibular rehabilitation
Number of subjects: 20
Study 33543735 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 20
Study 35813440 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX combined with dezocine-assisted anesthesia (Group A)
Number of subjects: 120
Study 35813440 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group B)
Number of subjects: 120
Study 34742284 — intervention group
Group type: EXPERIMENTAL
Intervention: SUMS intervention (10-15 hours of classroom sessions)
Number of subjects: 400
Study 34742284 — intervention group
Group type: EXPERIMENTAL
Intervention: SUMS intervention
Number of subjects: 400
Study 34742284 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 400
Study 36291165 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular hypertonic saline solution (6%)
Number of subjects: 0
Study 36291165 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular isotonic saline solution (0.9%)
Number of subjects: 0
Study 32605005 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich cocoa beverage
Number of subjects: 0
Study 32605005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33079393 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus exercise and physical therapy (LEAP)
Number of subjects: 547
Study 33079393 — intervention group
Group type: COMPARATOR
Intervention: Education-only (EO) lymphedema prevention
Number of subjects: 547
Study 33079393 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of lymphedema
Number of subjects: 547
Study 33079393 — intervention group
Group type: EXPERIMENTAL
Intervention: African American patients
Number of subjects: 547
Study 33079393 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 547
Study 33079393 — intervention group
Group type: EXPERIMENTAL
Intervention: Eastern Cooperative Oncology Group performance status >0
Number of subjects: 547
Study 33079393 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥1 positive lymph nodes
Number of subjects: 547
Study 33079393 — intervention group
Group type: EXPERIMENTAL
Intervention: No education beyond high school
Number of subjects: 547
Study 33079393 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwent chemotherapy
Number of subjects: 547
Study 33079393 — intervention group
Group type: EXPERIMENTAL
Intervention: Only axillary node dissection or sentinel node biopsy versus both
Number of subjects: 547
Study 36285476 — intervention group
Group type: EXPERIMENTAL
Intervention: Posture correction movements and stretching exercises during pregnancy from 16 to 18 to 35-37 weeks in six sessions for 45-60 min.
Number of subjects: 66
Study 36285476 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 66
Study 33983146 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Ankle Arthroplasty (TAA)
Number of subjects: 517
Study 33983146 — intervention group
Group type: COMPARATOR
Intervention: Ankle Arthrodesis (AA)
Number of subjects: 517
Study 32721549 — intervention group
Group type: EXPERIMENTAL
Intervention: CIT + HIIT
Number of subjects: 44
Study 32721549 — intervention group
Group type: COMPARATOR
Intervention: PLA + HIIT
Number of subjects: 44
Study 36372731 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestible sensor system (IS)
Number of subjects: 112
Study 36372731 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 112
Study 32492080 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily)
Number of subjects: 19114
Study 32492080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study 33410616 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg twice daily)
Number of subjects: 70
Study 33410616 — intervention group
Group type: COMPARATOR
Intervention: Rivaroxaban (10 mg once daily)
Number of subjects: 70
Study 32515246 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab treatment
Number of subjects: 117
Study 32515246 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control
Number of subjects: 117
Study 33742563 — intervention group
Group type: EXPERIMENTAL
Intervention: Aligned grafts
Number of subjects: 179
Study 33742563 — intervention group
Group type: COMPARATOR
Intervention: Non-aligned grafts
Number of subjects: 179
Study 36282186 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab (15–100 mg)
Number of subjects: 72
Study 36282186 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (21–140 mg)
Number of subjects: 72
Study 36282186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 32033535 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth (remote patient monitoring and video visits)
Number of subjects: 102
Study 32033535 — intervention group
Group type: COMPARATOR
Intervention: Standard transitions of care
Number of subjects: 102
Study 33501649 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes care processes
Number of subjects: 843
Study 33501649 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes self-management education
Number of subjects: 843
Study 33501649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition counselling
Number of subjects: 843
Study 33501649 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c levels
Number of subjects: 843
Study 33501649 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL cholesterol levels
Number of subjects: 843
Study 33501649 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure levels
Number of subjects: 843
Study 35317637 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency yoga breathing (with increased breath frequency)
Number of subjects: 38
Study 35317637 — intervention group
Group type: EXPERIMENTAL
Intervention: Bellows yoga breathing (with increased depth of respiration)
Number of subjects: 38
Study 35317637 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate nostril yoga breathing (with alternate nostril patency)
Number of subjects: 38
Study 35317637 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumblebee yoga breathing (with prolonged exhale)
Number of subjects: 38
Study 35317637 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath awareness (with attention to the breath)
Number of subjects: 38
Study 35317637 — intervention group
Group type: COMPARATOR
Intervention: Quiet seated rest
Number of subjects: 38
Study 34413142 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine N-butylbromide (20 mg IV)
Number of subjects: 25
Study 34413142 — intervention group
Group type: COMPARATOR
Intervention: Loperamide (4 mg orally)
Number of subjects: 25
Study 34413142 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-4FMFES
Number of subjects: 25
Study 34413142 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-FDG
Number of subjects: 25
Study 34413142 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of 18F-4FMFES and 18F-FDG
Number of subjects: 25
Study 36302061 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit modeling of communication skills
Number of subjects: 0
Study 36302061 — intervention group
Group type: COMPARATOR
Intervention: Implicit modeling of communication skills
Number of subjects: 0
Study 33821363 — intervention group
Group type: EXPERIMENTAL
Intervention: weekly paclitaxel plus cetuximab (wPTX-Cmab)
Number of subjects: 77
Study 34799380 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (2 years of maintenance therapy)
Number of subjects: 0
Study 34799380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34496938 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal priority robotic priming and impairment-oriented training (PRI)
Number of subjects: 40
Study 34496938 — intervention group
Group type: COMPARATOR
Intervention: Distal priority robotic priming and impairment-oriented training (DRI)
Number of subjects: 40
Study 32782076 — intervention group
Group type: EXPERIMENTAL
Intervention: Peppermint aromatherapy
Number of subjects: 0
Study 32782076 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 33710371 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low-dose CT (ULD-CT) with tin filtration (Sn140kV/50mAs)
Number of subjects: 30
Study 33710371 — intervention group
Group type: COMPARATOR
Intervention: Standard CT
Number of subjects: 30
Study 33710371 — intervention group
Group type: COMPARATOR
Intervention: Digital Radiographs (DRs)
Number of subjects: 30
Study 33710371 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low-dose CT (ULD-CT)
Number of subjects: 30
Study 33710371 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low-dose CT (ULD-CT) and Standard CT
Number of subjects: 30
Study 33710371 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Radiographs (VRs) from ULD-CT
Number of subjects: 30
Study 32547310 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg orally for six months
Number of subjects: 59
Study 32547310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 35930248 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver-based dressing
Number of subjects: 218
Study 35930248 — intervention group
Group type: COMPARATOR
Intervention: Conventional silver-free dressing
Number of subjects: 218
Study 33835077 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible epidural catheter 'B' (multiorifice wire‐reinforced polyamide nylon blend)
Number of subjects: 240
Study 33835077 — intervention group
Group type: COMPARATOR
Intervention: Flexible epidural catheter 'A' (single‐end hole wire‐reinforced polyurethane)
Number of subjects: 240
Study 35963834 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated virtual orbital wall reconstruction
Number of subjects: 50
Study 35963834 — intervention group
Group type: COMPARATOR
Intervention: Slice-by-slice virtual orbital reconstruction (Control)
Number of subjects: 50
Study 34816273 — intervention group
Group type: EXPERIMENTAL
Intervention: MF3: three meals per day
Number of subjects: 40
Study 34816273 — intervention group
Group type: COMPARATOR
Intervention: MF6: six meals per day
Number of subjects: 40
Study 35708951 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude expression manipulation during a collaborative task
Number of subjects: 190
Study 35708951 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude expression manipulation during an individual performance task
Number of subjects: 190
Study 35708951 — intervention group
Group type: COMPARATOR
Intervention: Control condition during collaborative task
Number of subjects: 190
Study 35708951 — intervention group
Group type: COMPARATOR
Intervention: Control condition during individual performance task
Number of subjects: 190
Study 33066812 — intervention group
Group type: EXPERIMENTAL
Intervention: Online cognitive behavioral therapy for insomnia (6 online sessions weekly + 2 face-to-face sessions)
Number of subjects: 48
Study 33066812 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 48
Study 35854224 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + NR
Number of subjects: 80
Study 35854224 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 80
Study 35854224 — intervention group
Group type: EXPERIMENTAL
Intervention: NR alone
Number of subjects: 80
Study 35854224 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study 32563599 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS)
Number of subjects: 212
Study 32563599 — intervention group
Group type: COMPARATOR
Intervention: Dietary advice alone
Number of subjects: 212
Study 32101426 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead intervention group
Number of subjects: 288
Study 32101426 — intervention group
Group type: COMPARATOR
Intervention: Injury intervention group
Number of subjects: 288
Study 32101426 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing units appearing clean
Number of subjects: 288
Study 32101426 — intervention group
Group type: COMPARATOR
Intervention: Housing units with more dust accumulation
Number of subjects: 288
Study 36246136 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (VDG)
Number of subjects: 61
Study 36246136 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise (EG)
Number of subjects: 61
Study 36246136 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D and exercise intervention (VEG)
Number of subjects: 61
Study 36246136 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 61
Study 33399016 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal sympathetic denervation (RDN)
Number of subjects: 19
Study 33399016 — intervention group
Group type: COMPARATOR
Intervention: Drug Adjustment (DA)
Number of subjects: 19
Study 34890827 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut Oral Immunotherapy (POIT) with a daily maintenance dose of 3,900 mg
Number of subjects: 12
Study 34890827 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut Oral Immunotherapy (POIT) after 1-month treatment discontinuation
Number of subjects: 12
Study 34890827 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker analysis during POIT
Number of subjects: 12
Study 34890827 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker analysis after 1-month discontinuation
Number of subjects: 12
Study 34890827 — intervention group
Group type: EXPERIMENTAL
Intervention: DBPCFC reaction severity after 12 months
Number of subjects: 12
Study 32358262 — intervention group
Group type: EXPERIMENTAL
Intervention: FineVision Pod FT toric IOL
Number of subjects: 60
Study 32358262 — intervention group
Group type: COMPARATOR
Intervention: AcrySof IQ PanOptix toric IOL
Number of subjects: 60
Study 32358262 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 34635511 — intervention group
Group type: EXPERIMENTAL
Intervention: FullFix intervention plus standard AOD care
Number of subjects: 130
Study 34635511 — intervention group
Group type: COMPARATOR
Intervention: Standard AOD care alone
Number of subjects: 130
Study 35773714 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Competence Promotion Program among Young Adolescents (SCPP-YA)
Number of subjects: 600
Study 35773714 — intervention group
Group type: COMPARATOR
Intervention: Standard school preventive curricula
Number of subjects: 600
Study 33542290 — intervention group
Group type: EXPERIMENTAL
Intervention: Airborne infrasound (IS; 6 Hz, 80-90 dB)
Number of subjects: 38
Study 33542290 — intervention group
Group type: COMPARATOR
Intervention: Sham devices
Number of subjects: 38
Study 34437756 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based treatment
Number of subjects: 262
Study 34437756 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 262
Study 34437756 — intervention group
Group type: COMPARATOR
Intervention: Comparison of app vs care-as-usual
Number of subjects: 262
Study 33420257 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved duck health and nutrition interventions
Number of subjects: 150
Study 33420257 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150
Study 36350379 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐enabled lifestyle intervention (WWACP)
Number of subjects: 351
Study 34001519 — intervention group
Group type: EXPERIMENTAL
Intervention: VEA intervention (community-driven water, sanitation and hygiene intervention)
Number of subjects: 332
Study 34001519 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 332
Study 35226532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0
Study 35226532 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study 33041017 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (discharge day 3)
Number of subjects: 60
Study 33041017 — intervention group
Group type: COMPARATOR
Intervention: Group B (discharge day 5)
Number of subjects: 60
Study 33041017 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 34967805 — intervention group
Group type: EXPERIMENTAL
Intervention: Preincision local anesthetic injection
Number of subjects: 24
Study 34967805 — intervention group
Group type: COMPARATOR
Intervention: Postprocedure local anesthetic injection
Number of subjects: 24
Study 32756520 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative peripheral nerve block (PNB)
Number of subjects: 60
Study 32756520 — intervention group
Group type: COMPARATOR
Intervention: Control group (morphine as primary analgesic)
Number of subjects: 60
Study 35954651 — intervention group
Group type: EXPERIMENTAL
Intervention: EG3s (eccentric contraction execution time = 3 s)
Number of subjects: 50
Study 35954651 — intervention group
Group type: EXPERIMENTAL
Intervention: EG6s (eccentric contraction execution time = 6 s)
Number of subjects: 50
Study 35954651 — intervention group
Group type: EXPERIMENTAL
Intervention: EG3s and EG6s
Number of subjects: 50
Study 34274044 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproterone acetate 25 mg/day
Number of subjects: 52
Study 34274044 — intervention group
Group type: COMPARATOR
Intervention: Spironolactone 100 mg/day
Number of subjects: 52
Study 32735221 — intervention group
Group type: EXPERIMENTAL
Intervention: Feel Stress Free app (6 weeks)
Number of subjects: 168
Study 32735221 — intervention group
Group type: EXPERIMENTAL
Intervention: Feel Stress Free app (4 weeks)
Number of subjects: 168
Study 32735221 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (6 weeks)
Number of subjects: 168
Study 35574717 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 30